Abstract:
Objective To investigate the molecular mechanism of IGF2BP2 activation of JAK2/STAT3 axis to promote the activation of inflammatory factors in cerebral ischemic stroke (CIS).
Methods Stroke-related molecules were screened by GEO database data. Peripheral blood samples from 60 patients with ischemic stroke were collected, and the expression of IGF2BP2 in peripheral blood samples was detected by ELISA. The ischemic stroke animal model was constructed and divided into blank control group ( NC group), ischemic stroke group (CIS group) and ischemic stroke + IGF2BP2 inhibitor CWI1-2 group (CIS + CWI1-2 group). The expressions of NeuN and NLRP3 were assessed by immunofluorescence. The expressions of interleukin(IL)-6, tumor necrosis factor-a (TNF-α), IL-1β, IL-8 and STAT3 in each group were detected by ELISA, and the expressions of JAK2, cleaved Caspase-1 (C-Caspase-1) and STAT3 in each group were detected by Western blotting.
Results Based on the GSE16561 and GSE22255 data sets in GEO, IGF2BP2 was overexpressed in CIS patients (n = 59 cases) (P < 0.05). The 60 CIS patients showed that the proportion of hyperlipidemia in the group with high expression of IGF2BP2 was higher than that in the group with low expression of IGFBP2 (P < 0.05). The results of animal model showed that compared with the NC group, the infarct size in CIS group was increased, while that in CIS + CWI1-2 group was decreased (F = 1303.00, MSwithin = 384.500, P < 0.01). Immunofluorescence results indicated that NeuN expression recovered after IGF2BP2 silencing, while NLRP3 expression decreased (P < 0.05). ELISA results showed that silenced IGFBP2 could decrease the expression of IL-6, tumor necrosis factor-a, IL-1β, IL-8 and STAT3 (P < 0.05). Western blotting results showed that silencing IGHFBP2 decreased the protein levels of JAK2, Caspase-1, NLRP3 and STAT3 (P < 0.05).
Conclusion IGF2BP2 promotes inflammatory factor activation in cerebral ischemic stroke by activating JAK2/STAT3 axis.